The Role of Cyclic Peptides in Modern Pharmaceutical Research
The landscape of pharmaceutical development is constantly evolving, with innovative molecules paving the way for novel treatments and advanced diagnostic tools. Among these, synthetic peptides, particularly cyclic peptides, are emerging as potent and versatile compounds. As a dedicated manufacturer of high-quality pharmaceutical intermediates, we at NINGBO INNO PHARMCHEM CO.,LTD. are at the forefront of supplying these critical building blocks.
One such compound gaining significant attention is Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl), identified by its CAS number 188968-51-6. This complex molecule, often referred to by its research name Cilengitide, is a synthetic cyclic pentapeptide. Its unique structure imparts enhanced stability and bioavailability compared to linear peptides, making it an attractive candidate for various therapeutic and diagnostic applications. Its white powder appearance and high purity are hallmarks of its quality, essential for its use as a pharmaceutical intermediate.
The primary area where this cyclic peptide demonstrates remarkable potential is in its function as an integrin inhibitor. Integrins are a group of transmembrane receptors that play crucial roles in cell-cell and cell-extracellular matrix adhesion. Aberrant integrin activity is implicated in numerous disease states, including cancer, where it drives processes like angiogenesis, invasion, and metastasis. Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl) specifically targets integrins αvβ3 and αvβ5, which are often overexpressed in tumor cells and neovasculature. By inhibiting these integrins, the compound can disrupt tumor growth and spread, presenting a promising avenue for anti-cancer therapies.
For researchers and procurement managers seeking this specialized compound, understanding its applications as a diagnostic reagent and a pharmaceutical intermediate is key. Its ability to selectively inhibit specific integrins makes it a valuable tool in experimental assays and in the synthesis of more complex therapeutic agents. When you look to buy Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl), choosing a reputable supplier in China like NINGBO INNO PHARMCHEM CO.,LTD. ensures you receive a product that meets stringent quality controls. We are a leading manufacturer committed to providing reliable, high-purity materials essential for your groundbreaking research and product development.
The demand for advanced peptide intermediates is growing, and our commitment to quality and innovation ensures we meet this need. If you are researching tumor therapy, diagnostic assays, or developing novel pharmaceuticals, consider integrating this potent cyclic peptide into your workflow. For inquiries regarding CAS 188968-51-6 price and bulk purchase options, please reach out to us. NINGBO INNO PHARMCHEM CO.,LTD. is your trusted partner for high-quality pharmaceutical materials.
Perspectives & Insights
Logic Thinker AI
“Its ability to selectively inhibit specific integrins makes it a valuable tool in experimental assays and in the synthesis of more complex therapeutic agents.”
Molecule Spark 2025
“When you look to buy Cyclo(L-arginylglycyl-L-a-aspartyl-D-phenylalanyl-N-methyl-L-valyl), choosing a reputable supplier in China like NINGBO INNO PHARMCHEM CO.”
Alpha Pioneer 01
“We are a leading manufacturer committed to providing reliable, high-purity materials essential for your groundbreaking research and product development.”